SCHEMBL866068

SCHEMBL866068

C/C=C/CC(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8186027 1.00
SCHEMBL8186028 1.00
SCHEMBL13406449 1.00
SCHEMBL458049 1.00
SCHEMBL14388431 1.00
SCHEMBL458050 1.00
SCHEMBL15703578 1.00
Hydrochloric Acid SCHEMBL713389 0.98 GRIK1 (0.66)
Hydrochloric Acid SCHEMBL712566 0.98 GRIK1 (0.66)
Hydrochloric Acid SCHEMBL2523802 0.98 GRIK1 (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004021981-A2 METHODS FOR THE PREPARATION OF β-AMINO ACIDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2004-03-18 WO claimed
US-20030113882-A1 Methods for the preparation of beta-amino acids WISCONSIN ALUMNI RESEARCH FOUNDATION 2003-06-19 US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
EP-4725952-A1 COMPOUNDS COMPRISING NON-CANONICAL AMINO ACIDS AND USES THEREOF ETH Zurich (CH) 2026-04-15 EP disclosed
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF RAYZEBIO, INC. 2023-05-25 US disclosed
WO-2023084124-A1 NOVEL BETA-LACTONE INHIBITORS OF HYDROLYTIC ENZYMES AND THEIR MEDICAL AND NON MEDICAL USES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-19 WO disclosed
EP-4180035-A1 NOVEL BETA-LACTONE INHIBITORS OF HYDROLYTIC ENZYMES AND THEIR MEDICAL AND NON MEDICAL USES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-17 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
CN-114540446-A High-yield culture medium for producing bleomycin E by using deep sea streptomycete gene engineering mutant strain and large-scale fermentation process thereof 华东理工大学 2022-05-27 CN disclosed
CN-111303247-B Marine cyclopeptide compound and application thereof in preparation of mycobacterium tuberculosis resistant medicines 中国科学院南海海洋研究所 2022-03-22 CN disclosed
EP-0787010-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-06 EP disclosed
WO-1996020949-A1 PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS SIBIA NEUROSCIENCES, INC. (US) 1996-07-11 WO disclosed
WO-1996012499-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-05-02 WO disclosed
WO-1995003321-A1 METHOD FOR ENDOMODIFICATION OF PROTEINS BIONEBRASKA, INC. (US) 1995-02-02 WO disclosed
US-5279954-A Coupling a nucleophile to protein; binding to other adjuvants BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA AND BIONEBRASKA (US) 1994-01-18 US disclosed
US-5234820-A Coupling nucleophile to protein, binding to auxiliary substance BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1993-08-10 US disclosed
EP-0479897-A1 ENZYMATICALLY BINDING BIOACTIVE MATERIALS TO PROTEINS BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1992-04-15 EP disclosed
WO-1991000296-A1 ENZYMATICALLY BINDING BIOACTIVE MATERIALS TO PROTEINS BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1991-01-10 WO disclosed
EP-0308983-A2 NMR imaging with Mn(II) coordination compositions SALUTAR, INC. (US) 1989-03-29 EP disclosed